IQVIA™ Real-World Insights Bibliography

Use of postmenopausal hormone therapy and risk of Alzheimer?s disease in Finland: nationwide case-control study
Author(s): Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, Mikkola TS.
Affiliations(s): EPID Research Oy, Espoo, Finland
Publication(s):  BMJ
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Mental health,
2019
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Postmenopausal hormone therapy is accompanied by elevated risk for uterine prolapse
Author(s): Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS
Affiliations(s): EPID Research Oy, Espoo, Finland
Publication(s):  Menopause
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Patient Registries & Real-World Study Methods,
2019
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Increased risk for stress urinary incontinence in women with postmenopausal hormone therapy
Author(s): Rahkola-Soisalo P, Savolainen-Peltonen H, Gissler M, Hoti F, Vattulainen P, Ylikorkala O, Mikkola TS
Affiliations(s): EPID Research Oy, Espoo, Finland
Publication(s):  Int Urogynecol J
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Patient Registries & Real-World Study Methods,
2019
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
CLUE: Consequences for life of children with in utero exposure to metformin in Finland
Author(s): Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch, Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Affiliations(s): Merck KGaA: Kerstin Brand, Judith Schlachter, Emmanuelle Boutmy, Caroline Foch IQVIA (SF-EPID): Pasi Korhonen, Katja Hakkarainen, Jaak Sonajalg, Minna Vehkala, Laura Saarelainen
Publication(s):  The International Diabetes Federation (IDF) Congress 2019
Document Type(s): Oral presentation,
Countries: Finland,
C:
Y:
Diabetes,
2019
  L:
A:
English
Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Observational study, Population Based Study, Public Health, Retrospective cohort analysis, Retrospective database analysis,
  Add to report
 
 
Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time.
Author(s): Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM
Affiliations(s): VL: Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland. JM, KMH: StatFinn & EPID Research. AL, TMJ: Janssen-Cilag.
Publication(s):  Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273.
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Oncology,
2019
  L:
A:
English
Clinical setting: hospital, Epidemiological study, Observational study, Retrospective cohort analysis,
  Add to report
 
 
A Survey Among Health Care Professionals to Assess Their Knowledge and Understanding on Darzalex® (Daratumumab) Educational Materials Regarding the Risk of Interference for Blood Typing in 12 European Countries
Author(s): Mathieu Rosé, Intissar Bourahla, Alessandro Ghiddi, Assem Al-Akabawi, Edmond Chan, Massoud Toussi
Affiliations(s): IQVIA, Courbevoie, France; Janssen EMEA, Medical Affairs, Italy; Janssen EMEA, Medical Affairs, UK
Publication(s):  Presented at ISPE?s 35th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE 2019), August 24?28, 2019 at the Pennsylvania Convention Center, Philadelphia, PA, USA.
Document Type(s): Poster,
Countries: Austria, Czech, Denmark, Finland, France, Germany, Hungary, Norway, Slovakia, Spain, Sweden, Switzerland,
Click here for the abstract
C:
Y:
Hematology, Oncology,
2019
  L:
A:
English
Public Health, Survey research,
  Add to report
 
 
Pregnancy and Infant Outcomes with Interferon Beta: Data from the European Interferon Beta Pregnancy Registry and MS Pregnancy study conducted in Finland and Sweden
Author(s): "Kerstin Hellwig*, Yvonne Geissbuehler2, Meritxell Sabidó3, Catrinel Popescu4, Alessandra Adamo5, Joachim Klinger6, Peter Huppke7, Asher Ornoy8, Pasi Korhonen9, Kjell-Morten Myhr10, Scott Montgomery11, Sarah Burkill11, European Interferon Beta Pregnancy Study Group"
Affiliations(s): *Katholisches Klinikum Bochum, St Josef-Hospital Universitatsklinikum, Bochum, Germany; 9StatFinn & EPID Research, Espoo, Finland
Publication(s):  AAN, Philadelphia, USA, 4-10 May 2019
Document Type(s): Oral presentation,
Countries: Europe, Finland, Sweden,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Epidemiological study, Population Based Study,
  Add to report
 
 
No increased risk of spontaneous abortion and ectopic pregnancy after exposure to interferon-beta prior to or during pregnancy: Results from register-based Nordic study among women with MS
Author(s): R. Juuti1, K. M. Hakkarainen 1, S. Burkill 2, Y. Geissbuehler 3, M. Sabidó 4, C. Popescu 5, A. Adamo 6, J. Hillert 2, S. Cnattingius 2, M. Artama 7, A. Verkkoniemi-Ahola 8, K.-M. Myhr 9, J. Mehtälä 1, S. Bahmanyar 2, S. Montgomery 2,10, P. Korhonen 1 and the European Interferon Beta Pregnancy Study Group
Affiliations(s): 1StatFinn-EPID Research, Espoo, Finland
Publication(s):  EAN, Oslo, Norway, June 29-2 July, 2019
Document Type(s): Oral presentation,
Countries: Finland, Germany, Norway, Sweden, Switzerland, UK,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Epidemiological study, Population Based Study, Retrospective database analysis,
  Add to report
 
 
Prevalence of infant outcomes at birth after exposure to interferon beta prior to or during pregnancy: A register-based cohort study in Finland and Sweden among women with MS
Author(s): Pia Vattulainen1, Sarah Burkill2, Yvonne Geissbuehler3, Meritxell Sabidó4, Catrinel Popescu5, Kiliana Suzart-Woischnik6, Kjell-Morten Myhr7, Scott Montgomery2,8, Pasi Korhonen1 the European Interferon Beta Pregnancy Study Group and the Nordic MS Pregnancy & Interferon Beta study group
Affiliations(s): 1StatFinn-EPID Research, Espoo, Finland
Publication(s):  ECTRIMS, Stockholm, Sweden, 11-13 September, 2019
Document Type(s): Poster,
Countries: Finland, Sweden,
Click here for the abstract
C:
Y:
Neurological disorders,
2019
  L:
A:
English
Epidemiological study, Population Based Study, Retrospective cohort analysis,
  Add to report
 
 
Patient and caregiver indirect costs after acute cardiovascular events in Europe.
Author(s): Sidelnikov E1, Gerlier L2, Kutikova L1, Amarenco P3, Kotseva K4, Annemans L5
Affiliations(s): 1 Amgen (Europe) GmbH, Zug, Switzerland 2 IQVIA, Zaventem, Belgium 3 Paris-Diderot-Sorbonne University, Paris, France 4 National Heart & Lung Institute, Imperial College London, London, UK 5 Ghent University, Ghent, Belgium
Publication(s):  ISPOR 21st Annual European Congress, 2018, November 10-14, Barcelona, Spain
Document Type(s): Oral presentation,
Countries: Austria, Bulgaria, Croatia, Czech, Denmark, Finland, Germany, Greece, Italy, Norway, Romania, Slovakia, Slovenia,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2018
  L:
A:
English
Burden of illness, Cost of illness,
  Add to report
 
 
 1 of 8 Next Page Last Page